News
On May 15, 2025, a jury returned a verdict finding Amgen Inc. (“Amgen”) liable for antitrust violations and awarding Regeneron Pharmaceuticals, ...
Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, ...
27m
The Chosun Ilbo on MSNTrump drug pricing order opens doors for Korean biosimilarsA sweeping executive order signed by U.S. President Donald Trump to slash domestic drug prices has drawn fierce opposition ...
Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...
Tess Stynes - profile from The Wall Street Journal. News, articles, biography and photos.
Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.
Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results